Browsing: Clinical Trial

Clinical Can remdesivir treatment improve recovery time for COVID-19 patients?

Data from the Adaptive COVID-19 Treatment Trial (ACTT) has demonstrated that remdesivir treatment reduces recovery time in patients hospitalized with severe SARS-CoV-2 infections, requiring supplemental oxygen therapy. The results support remdesivir as the standard treatment for patients hospitalized with COVID-19.

1 2 3 10